Clinical pharmacokinetics of zidovudine. An overview of current data.
about
Phosphorylation of nucleoside analog antiretrovirals: a review for clinicians.Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity.Multidose pharmacokinetics of ritonavir and zidovudine in human immunodeficiency virus-infected patientsPharmacokinetics of zidovudine phosphorylation in peripheral blood mononuclear cells from patients infected with human immunodeficiency virus.Sensitive and specific radioimmunoassay for fialuridine: initial assessment of pharmacokinetics after single oral doses to healthy volunteersSingle-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infectionThe effects of indomethacin and naproxen on zidovudine pharmacokineticsPharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062).Absence of effect of trimethoprim-sulfamethoxazole on pharmacokinetics of zidovudine in patients infected with human immunodeficiency virusA swift and facile radiosynthesis of [alpha-32P]-3'-azido-3'-deoxythymidine 5'-triphosphate (AZT triphosphate)Pharmacokinetics of concomitantly administered foscarnet and zidovudine for treatment of human immunodeficiency virus infection (AIDS Clinical Trials Group protocol 053)Effects of standard breakfast on pharmacokinetics of oral zidovudine in patients with AIDS.Pharmacokinetics of 3'-azido-3'-deoxythymidine and its catabolites and interactions with probenecid in rhesus monkeys.Pharmacokinetics of the anti-human immunodeficiency virus nucleoside analog stavudine in cynomolgus monkeysPharmacokinetic interaction between rifampin and zidovudine.Management of antiretroviral drug therapy in human immunodeficiency virus infection.Pharmacokinetics of 2-fluorodideoxycytidine (2FddC) in patients infected with human immunodeficiency virusZidovudine pharmacokinetics in zidovudine-induced bone marrow toxicity.Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection.Pharmacokinetics of zidovudine after the initial single dose and during chronic-dose therapy in HIV-infected patients.Synthesis and in vitro antibacterial activity of novel 5'-O-analog derivatives of zidovudine as potential prodrugs.Pharmacokinetics and metabolism of the novel synthetic C-nucleoside, 1-(2-deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.Pharmacokinetics of zidovudine and acetaminophen in a patient on chronic acetaminophen therapy.Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations.Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses.Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.Pharmacokinetics of Zidovudine in HIV-Positive Patients with Liver Disease
P2860
Q31975873-8F70BA7A-BE64-4449-8811-F3378619A5B5Q33502564-240FFE22-9A31-4903-9EF6-68FFAD59A42BQ33694387-7EF9B48A-D127-4A11-BAB4-FBACE8CA1DDEQ33754634-C1117A34-056F-4C39-9E94-3BF3F8449BE7Q33759100-D1D93005-C747-43E9-B68B-F38482763414Q33977187-3EBFF018-14AA-424D-8A47-8D1496ABB070Q34345495-EF13CB54-B3A3-4ACC-9C13-4BFE877A0926Q35120894-57B82B86-94F6-4992-A819-02A0BCABBA01Q35122047-6D4E853F-9FBC-4FFA-8078-1CD667CD6A7EQ35890138-F86DFAF6-CD75-470A-89CE-E24A7A60362EQ35894405-E3D4A429-7BAB-4304-BF65-383EA033CF6EQ35897391-9D3CC227-2CEA-4637-961B-2B9BAE917DD7Q36753621-AB138707-9A05-4998-A40D-93612C42D9EBQ39866053-F8EBCE0B-D221-447E-83A4-45329A918F0AQ39866285-5194159C-39CE-4114-BA65-8E29592637B0Q40626125-504A48E9-9603-40E9-BDEF-AA8FB4B9D941Q41819493-2CF4EF7F-927A-48FD-A60A-549DA8E86785Q42264778-3B8B8B61-BDE1-4DE2-BDF7-1EFBD15216D0Q42281858-F3042069-6C5D-4BBC-8F00-0609CDE3D49DQ43201467-78D6393A-7B85-4460-AC01-2798CD269D48Q43980402-23080722-31EB-4A95-8DBB-394E3BB9BD27Q44098680-E93BBAF2-FBCE-4061-BD55-BB86F001AF02Q44199759-5F1CD76F-F633-4203-9D6E-349C4E22BE4FQ45932455-74E4FD52-F625-458C-831C-93AABEA33065Q50597914-9065B8FE-FA08-452D-8FF1-931DF894A0A9Q50974898-541D6A13-A6EA-477F-9B70-C3142D6ABB9BQ58292513-99F5E252-49D4-4383-B8D1-C962A7349C78
P2860
Clinical pharmacokinetics of zidovudine. An overview of current data.
description
1989 nî lūn-bûn
@nan
1989 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Clinical pharmacokinetics of zidovudine. An overview of current data.
@ast
Clinical pharmacokinetics of zidovudine. An overview of current data.
@en
type
label
Clinical pharmacokinetics of zidovudine. An overview of current data.
@ast
Clinical pharmacokinetics of zidovudine. An overview of current data.
@en
prefLabel
Clinical pharmacokinetics of zidovudine. An overview of current data.
@ast
Clinical pharmacokinetics of zidovudine. An overview of current data.
@en
P1476
Clinical pharmacokinetics of zidovudine. An overview of current data.
@en
P2093
Collins JM
Unadkat JD
P356
10.2165/00003088-198917010-00001
P577
1989-07-01T00:00:00Z
P6179
1005506416